ImmunityBio (IBRX) Current Deferred Revenue (2014 - 2015)
ImmunityBio (IBRX) recorded Current Deferred Revenue of $235,000 in Q3 2015, down 2.5% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Current Deferred Revenue (2014 - 2015) Analysis & Trends
At the end of FY2014, ImmunityBio reported Current Deferred Revenue of $521,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.71 Bn | 1,105.29 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.55 Bn | 536.07 Bn | 17.26 Bn |
| 3 | AbbVie | 501.02 Bn | 474.13 Bn | 12.70 Bn |
| 4 | Merck | 368.18 Bn | 322.56 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.89 Bn | 261.88 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 236.60 Bn | 191.99 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn |
| 9 | Pfizer | 169.77 Bn | 116.42 Bn | 10.94 Bn |
| 10 | ImmunityBio | 9.11 Bn | 7.87 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 235,000.00 |
| Jun 30, 2015 | 241,000.00 |
| Dec 31, 2014 | 521,000.00 |
API Access
ImmunityBio Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();